当前位置: 首页 > 详情页

The relationship between fat distribution in central region and comorbidities in obese people: Based on NHANES 2011-2018

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Shijitan Hosp, Dept Gastrointestinal Surg, Beijing, Peoples R China [2]Capital Med Univ, Beijing Shijitan Hosp, Dept Clin Nutr, Beijing, Peoples R China [3]Capital Med Univ, Xuanwu Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China [4]Key Lab Canc Food Special Med Purposes FSMP State, Beijing, Peoples R China [5]Capital Med Univ, Beijing Int Sci & Technol Cooperat Base Canc Metab, Beijing, Peoples R China [6]Univ Chinese Acad Sci, Zhejiang Canc Hosp, Dept Colorectal Surg, Canc Hosp, Hangzhou, Zhejiang, Peoples R China
出处:
ISSN:

关键词: obesity fat distribution comorbidity public health NHANES

摘要:
BackgroundCentral obesity is closely related to comorbidity, while the relationship between fat accumulation pattern and abnormal distribution in different parts of the central region of obese people and comorbidity is not clear. This study aimed to explore the relationship between fat distribution in central region and comorbidity among obese participants. MethodsWe used observational data of NHANES 2011-2018 to identify 12 obesity-related comorbidities in 7 categories based on questionnaire responses from participants. Fat distribution is expressed by fat ratio, including Android, Gynoid, visceral, subcutaneous, visceral/subcutaneous (V/S), and total abdominal fat ratio. Logistic regression analysis were utilized to elucidate the association between fat distribution and comorbidity. ResultsThe comorbidity rate was about 54.1% among 4899 obese participants (weighted 60,180,984, 41.35 +/- 11.16 years, 57.5% female). There were differences in fat distribution across the sexes and ages. Among men, Android fat ratio (OR, 4.21, 95% CI, 1.54-11.50, P-trend=0.007), visceral fat ratio (OR, 2.16, 95% CI, 1.42-3.29, P-trend<0.001) and V/S (OR, 2.07, 95% CI, 1.43-2.99, P-trend<0.001) were independent risk factors for comorbidity. Among these, there was a "J" shape correlation between Android fat ratio and comorbidity risk, while visceral fat ratio and V/S exhibited linear relationships with comorbidity risk. The Gynoid fat ratio (OR, 0.87, 95%CI, 0.80-0.95, P-trend=0.001) and subcutaneous fat ratio (OR, 0.81, 95%CI, 0.67-0.98, P-trend=0.016) both performed a protective role in the risk of comorbidity. In women, Android fat ratio (OR, 4.65, 95% CI, 2.11-10.24, P-trend=0.020), visceral fat ratio (OR, 1.83, 95% CI, 1.31-2.56, P-trend=0.001), and V/S (OR, 1.80, 95% CI, 1.32-2.45, P-trend=0.020) were also independent risk factors for comorbidity, with a dose-response relationship similar to that of men. Only the Gynoid fat ratio (OR, 0.93, 95% CI, 0.87-0.99, P-trend=0.016) had a protective effect on female comorbidity. This association was also seen in obese participants of different age groups, comorbidity numbers, and comorbidity types, although it was more statistically significant in older, complex comorbidity, cardiovascular, cerebrovascular, and metabolic diseases. ConclusionsIn the obese population, there were strong correlation between fat distribution in central region and comorbidity, which was affected by sex, age, number of comorbidities, and type of comorbidity.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 2 区 医学
小类 | 2 区 内分泌学与代谢
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 内分泌学与代谢
JCR分区:
出版当年[2021]版:
Q1 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q2 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Shijitan Hosp, Dept Gastrointestinal Surg, Beijing, Peoples R China [2]Capital Med Univ, Beijing Shijitan Hosp, Dept Clin Nutr, Beijing, Peoples R China [3]Capital Med Univ, Xuanwu Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China [4]Key Lab Canc Food Special Med Purposes FSMP State, Beijing, Peoples R China [5]Capital Med Univ, Beijing Int Sci & Technol Cooperat Base Canc Metab, Beijing, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Shijitan Hosp, Dept Gastrointestinal Surg, Beijing, Peoples R China [2]Capital Med Univ, Beijing Shijitan Hosp, Dept Clin Nutr, Beijing, Peoples R China [3]Capital Med Univ, Xuanwu Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China [4]Key Lab Canc Food Special Med Purposes FSMP State, Beijing, Peoples R China [5]Capital Med Univ, Beijing Int Sci & Technol Cooperat Base Canc Metab, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16399 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院